
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-09-01-2008
- Volume 20
- Issue 9
Back to school
It's back to school. Another summer has flown past and here we all meet again, ready to return to work and face the winter with renewed energies. Welcome back!
It's back to school. Another summer has flown past and here we all meet again, ready to return to work and face the winter with renewed energies. Welcome back!
While some of you have been enjoying a well-deserved break during July and August, at Pharmaceutical Technology Europe (PTE) we have continued to work hard, not only to bring you the most up-to-date information regarding the European pharmaceutical and biopharmaceutical industries, but to do so in an exciting, innovative and comprehensive way. This effort has resulted in the creation of new sections, and the implementation of a series of developments and improvements in the PTE magazine and website. We are confident you will enjoy them.
So, what's new? In the PTE magazine we have introduced a brand new section where we'll be tackling strategic business and marketing issues, corporate policy, legislation, finance and much more through interviews, industry reports and opinion articles. This section will be called Business Focus and can be found in pages 85–98.
Additionally, as CPhI/ICSE and Technopharm/PowTech are taking place at the end of the month in Germany, we have dedicated some space in the September issue to preview these events, present the profiles of a number of exhibiting companies and showcase some of the products that will be displayed at the show.
In the PTE website (
In the Online Exclusives section in our homepage, you will find a series of quick interviews with key members of the pharmaceutical and biopharmaceutical industries, together with additional feature articles and reviews for quick access and reference. Lluis Ribas de Pouplana (Omnia Molecular) and Fraser Black (SAS GE Healthcare) have been two of our 'victims' so far. You can find this section at
And last but not least, we have created two new sections to host Case Studies and White Papers. If your company would like to see its case studies and white papers featured on our website, please do not hesitate to get in touch.
In summary, this is a September issue packed to the brim with feature articles, interviews, insights and opinions... Enjoy it! Also, if you are going to CPhI, please come and visit us at Hall 3.1 Stand 31H19. See you in Frankfurt!
Articles in this issue
about 17 years ago
Testing time for stem cellsabout 17 years ago
Effective complaint handling, investigations and adverse event reportingabout 17 years ago
Joining the parallel linesabout 17 years ago
Regulatory affairs: additional value?about 17 years ago
Bruce Daviesabout 17 years ago
Pseudo-polymorphic conversion by near-infrared spectroscopyabout 17 years ago
Renaissance manabout 17 years ago
The winner's circleabout 17 years ago
Bioanalysis of recombinant proteins by mass spectrometryabout 17 years ago
Modulation of drug release from hydrophilic matricesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





